Ben M Swinkels1, Jurriën M Ten Berg1, Johannes C Kelder1, Freddy E Vermeulen2, Wim Jan Van Boven3, Bas A de Mol3. 1. Department of Cardiology, St. Antonius Hospital, Nieuwegein, Netherlands. 2. Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein, Netherlands. 3. Department of Cardiothoracic Surgery, Amsterdam University Medical Center, Location Academic Medical Center, Amsterdam, Netherlands.
Abstract
OBJECTIVES: Longer aortic cross-clamp (ACC) time is associated with decreased early survival after cardiac surgery. Because maximum follow-up in previous studies on this subject is confined to 28 months, it is unknown whether this adverse effect is sustained far beyond this term. We aimed to determine whether longer ACC time was independently associated with decreased late survival after isolated aortic valve replacement in patients with severe aortic stenosis during 25 years of follow-up. METHODS: In this retrospective cohort study, multivariable analysis was performed to identify possible independent predictors of decreased late survival, including ACC and cardiopulmonary bypass (CPB) time, in a cohort of 456 consecutive patients with severe aortic stenosis, who had undergone isolated aortic valve replacement between 1990 and 1993. RESULTS: Mean follow-up was 25.3 ± 2.7 years. Median (interquartile range) and mean ACC times were normal: 63.0 (20.0) and 64.2 ± 16.1 min, respectively. Age, operative risk scores and New York Heart Association class were similar in patients with ACC time above, versus those with ACC time below the median. Longer ACC time was independently associated with decreased late survival: hazards ratio (HR) 1.01 per minute increase of ACC time (95% confidence interval [CI] 1.00-1.02; P = 0.012). Longer CPB time was not associated with decreased late survival (HR 1.00 per minute increase of CPB time [95% CI 1.00-1.00; P = 0.30]). CONCLUSIONS: Longer ACC time, although still within normal limits, was independently associated with decreased late survival after isolated aortic valve replacement in patients with severe aortic stenosis.
OBJECTIVES: Longer aortic cross-clamp (ACC) time is associated with decreased early survival after cardiac surgery. Because maximum follow-up in previous studies on this subject is confined to 28 months, it is unknown whether this adverse effect is sustained far beyond this term. We aimed to determine whether longer ACC time was independently associated with decreased late survival after isolated aortic valve replacement in patients with severe aortic stenosis during 25 years of follow-up. METHODS: In this retrospective cohort study, multivariable analysis was performed to identify possible independent predictors of decreased late survival, including ACC and cardiopulmonary bypass (CPB) time, in a cohort of 456 consecutive patients with severe aortic stenosis, who had undergone isolated aortic valve replacement between 1990 and 1993. RESULTS: Mean follow-up was 25.3 ± 2.7 years. Median (interquartile range) and mean ACC times were normal: 63.0 (20.0) and 64.2 ± 16.1 min, respectively. Age, operative risk scores and New York Heart Association class were similar in patients with ACC time above, versus those with ACC time below the median. Longer ACC time was independently associated with decreased late survival: hazards ratio (HR) 1.01 per minute increase of ACC time (95% confidence interval [CI] 1.00-1.02; P = 0.012). Longer CPB time was not associated with decreased late survival (HR 1.00 per minute increase of CPB time [95% CI 1.00-1.00; P = 0.30]). CONCLUSIONS: Longer ACC time, although still within normal limits, was independently associated with decreased late survival after isolated aortic valve replacement in patients with severe aortic stenosis.
Authors: Antonio Salsano; Daniele Roberto Giacobbe; Elena Sportelli; Guido Maria Olivieri; Roberto Natali; Martina Prevosto; Valerio Del Bono; Claudio Viscoli; Francesco Santini Journal: Interact Cardiovasc Thorac Surg Date: 2018-09-01
Authors: N Bleese; V Döring; P Kalmar; H Pokar; M J Polonius; D Steiner; G Rodewald Journal: J Thorac Cardiovasc Surg Date: 1978-03 Impact factor: 5.209
Authors: Nael Al-Sarraf; Lukman Thalib; Anne Hughes; Maighread Houlihan; Michael Tolan; Vincent Young; Eillish McGovern Journal: Int J Surg Date: 2010-10-20 Impact factor: 6.071
Authors: Juha Nissinen; Fausto Biancari; Jan-Ola Wistbacka; Timo Peltola; Pertti Loponen; Pekka Tarkiainen; Markku Virkkilä; Matti Tarkka Journal: Perfusion Date: 2009-12-10 Impact factor: 1.972
Authors: H A Verheul; R B van den Brink; B J Bouma; G Hoedemaker; A C Moulijn; E Dekker; P Bossuyt; A J Dunning Journal: J Am Coll Cardiol Date: 1995-11-01 Impact factor: 24.094
Authors: Alina Zubarevich; Marcin Szczechowicz; Lukman Amanov; Arian Arjomandi Rad; Anja Osswald; Saeed Torabi; Arjang Ruhparwar; Alexander Weymann Journal: Life (Basel) Date: 2022-06-29